PCT Europe 2017, Amsterdam. In partnership with Synergy CRO, Cyntegrity presents the concept of #RealRBM: Hype or Common Sense. The main topics of the presentation are: The concept of integrity in Risk-based Monitoring Risks perception - differences in risk assessment between a sponsor and a CRO [...]
Interested in holistic implementation of the RBM? Let's talk in London by Clinical Operations Strategy Meeting (EU 2016) on Monday 11th July 2016. See the RBM session plan for the meeting: Interested in scheduling a meeting during the conference or after?[button link="https://cyntegrity.com/contact-info/" color="default" size="" stretch="" type="" shape="" [...]
PCT Europe is back for 2018, bringing you the latest information from across the clinical trials spectrum and providing you with direct access to the industry’s leading innovators.
The Society for Clinical Data Management (SCDM) is a non-profit, international organization.
DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide.
Now in its 10th edition, World Drug Safety Americas 2018 is the global leading drug safety strategy-led event for pharma and biotech organisations. Going into 2018, drug safety is still an important topic as priorities change and the regulatory backdrop continues to evolve. Now is the time [...]
Our online KRI (Key Risk Indicator) survey indicated that finding the right calculation method seems the most challenging aspect of the application of KRIs. In addition our survey showed that the vast majority (> 95%) makes use of KRIs. Do these results surprise you?
Blockchain technology is the biggest achievement in cryptography of the past decade. Source Data Verification (SDV), which consumes about 20–30% of the clinical trial budget nowadays, will become redundant when blockchain technology disrupts the pharma industry.
Dr. Johann Proeve, our Chief Scientific Officer, is one of the keynote speakers at the Association for Clinical Data Management (ACDM). We hope your busy schedule will allow you to meet with Johann.
Adaptive Monitoring is not a “status quo”, it is a dynamic response to clinical research that drives monitoring scope and activities to the evolving areas of greatest need which have the most potential to positively impact. Each clinical study requires its own tailored monitoring approach ensuring risks are minimized.